The most common GI side effects of these agents include nausea, vomiting, diarrhoea, abdominal pain, and constipation
Hence, this raises the possibility that other antioxidants and potent modifiers of redox regulation, which have shown promise in pre-clinical models of ALS, should be re-examined in clinical trials (Table 3)
CL Answer Are There Supplements That Help Treat POTS (Postural Orthostatic Tachycardia Syndrome)
(2021) reaffirms the cardioprotective potential of tirzepatide, which is essential for patients with DM2 and high CV risk
Fournier, C
More recently, in March 2024, Wegovy was This approval followed promising results from novo Nordisks SELECT trial, which followed 17,604 adults with obesity or overweight and cardiovascular disease but no history of diabetes